Skip to main content
Erschienen in: Digestive Diseases and Sciences 6/2018

21.03.2018 | Original Article

Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas

verfasst von: T. Mizumoto, T. Hiyama, S. Oka, N. Yorita, K. Kuroki, M. Kurihara, Y. Yoshifuku, Y. Sanomura, Y. Urabe, Y. Murakami, K. Arihiro, S. Tanaka, K. Chayama

Erschienen in: Digestive Diseases and Sciences | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

According to the Japanese Esophageal Society (JES) guidelines, risk factors for lymph node (LN) metastasis in the muscularis mucosa (MM)/submucosa to a depth of up to 200 μm (SM1) in cases of esophageal squamous cell carcinomas (ESCCs) include the presence of lymphatic invasion (ly), venous invasion (v), infiltration pattern (INF)c, and SM1. The long-term prognoses of these patients are unclear, and there are very few reports on the validation of the curative criteria for MM/SM1 ESCCs.

Aims

To examine the long-term prognoses of these patients and the risk factors for LN metastasis of MM/SM1 ESCCs after endoscopic resection (ER).

Methods

This study included patients with MM/SM1 ESCCs who underwent ER at Hiroshima University Hospital from December 1990 to November 2016. We evaluated the clinicopathological characteristics of 98 patients and overall survival, disease-specific survival, recurrence-free survival, and recurrence rates in the e-curative and non-e-curative groups.

Results

The mean observation period was 75 months. There was no significant difference in disease-specific survival rate between the e-curative and non-e-curative groups (100 vs. 98%). There was no significant difference in disease-specific survival rates between the groups (100 vs. 98%). In contrast, the LN recurrence-free survival rate in patients with INFa, ly(−), and v(−) was significantly higher than that in patients with INFb/c, ly(+), or v(+) (100 and 87%, P < 0.05).

Conclusion

Contrary to the JES guidelines, our findings suggest that new criteria (MM/SM1, INFa, negative vertical margin (VM0), ly[-], and v[-]) may be associated with curative ER without additional treatment.
Literatur
1.
Zurück zum Zitat Moreira LF, Kamikawa Y, Naomoto Y, Haisa M, Orita K. Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc. 1995;5:171–175.PubMed Moreira LF, Kamikawa Y, Naomoto Y, Haisa M, Orita K. Endoscopic mucosal resection for superficial carcinoma and high-grade dysplasia of the esophagus. Surg Laparosc Endosc. 1995;5:171–175.PubMed
2.
Zurück zum Zitat Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275–280.CrossRefPubMed Urabe Y, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Advantages of endoscopic submucosal dissection versus endoscopic oblique aspiration mucosectomy for superficial esophageal tumors. J Gastroenterol Hepatol. 2011;26:275–280.CrossRefPubMed
3.
Zurück zum Zitat Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae–a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed Katada C, Muto M, Momma K, et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae–a multicenter retrospective cohort study. Endoscopy. 2007;39:779–783.CrossRefPubMed
4.
Zurück zum Zitat Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–390.CrossRefPubMed Shimizu Y, Tsukagoshi H, Fujita M, Hosokawa M, Kato M, Asaka M. Long-term outcome after endoscopic mucosal resection in patients with esophageal squamous cell carcinoma invading the muscularis mucosae or deeper. Gastrointest Endosc. 2002;56:387–390.CrossRefPubMed
5.
Zurück zum Zitat Ono H. Endoscopic submucosal dissection for early gastric cancer. J Dig Dis. 2005;6:119–121. Ono H. Endoscopic submucosal dissection for early gastric cancer. J Dig Dis. 2005;6:119–121.
6.
Zurück zum Zitat Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–694.CrossRefPubMed Fujishiro M, Yahagi N, Kakushima N, et al. Endoscopic submucosal dissection of esophageal squamous cell neoplasms. Clin Gastroenterol Hepatol. 2006;4:688–694.CrossRefPubMed
7.
Zurück zum Zitat Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:S67–S70.CrossRefPubMed Oyama T, Tomori A, Hotta K, et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol. 2005;3:S67–S70.CrossRefPubMed
8.
Zurück zum Zitat Takahashi H, Arimura Y, Masao H, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72:255–264.CrossRefPubMed Takahashi H, Arimura Y, Masao H, et al. Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc. 2010;72:255–264.CrossRefPubMed
9.
Zurück zum Zitat Tsujii Y, Nishida T, Nishiyama O, et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy. 2015;47:775–783.CrossRefPubMed Tsujii Y, Nishida T, Nishiyama O, et al. Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study. Endoscopy. 2015;47:775–783.CrossRefPubMed
10.
Zurück zum Zitat Nagami Y, Ominami M, Shiba M, et al. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia. Dig Liver Dis. 2017;49:427–433.CrossRefPubMed Nagami Y, Ominami M, Shiba M, et al. The five-year survival rate after endoscopic submucosal dissection for superficial esophageal squamous cell neoplasia. Dig Liver Dis. 2017;49:427–433.CrossRefPubMed
11.
Zurück zum Zitat Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–551.CrossRefPubMed Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–551.CrossRefPubMed
12.
Zurück zum Zitat Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–866.CrossRefPubMed Ono S, Fujishiro M, Niimi K, et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc. 2009;70:860–866.CrossRefPubMed
13.
Zurück zum Zitat Joo DC, Kim GH, Park DY, Jhi JH, Song GA. Long-term outcome after endoscopic sub-mucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver. 2014;8:612–618.CrossRefPubMedPubMedCentral Joo DC, Kim GH, Park DY, Jhi JH, Song GA. Long-term outcome after endoscopic sub-mucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study. Gut Liver. 2014;8:612–618.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000–1008.CrossRefPubMed
15.
Zurück zum Zitat Miwata T, Oka S, Tanaka S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc. 2016;30:4049–4056.CrossRefPubMed Miwata T, Oka S, Tanaka S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc. 2016;30:4049–4056.CrossRefPubMed
16.
17.
Zurück zum Zitat Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–575.CrossRefPubMed Araki K, Ohno S, Egashira A, Saeki H, Kawaguchi H, Sugimachi K. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis. Cancer. 2002;94:570–575.CrossRefPubMed
18.
Zurück zum Zitat Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–480.CrossRefPubMed Eguchi T, Nakanishi Y, Shimoda T, et al. Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: analysis of 464 surgically resected cases. Mod Pathol. 2006;19:475–480.CrossRefPubMed
19.
Zurück zum Zitat Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–1293.CrossRefPubMed Tajima Y, Nakanishi Y, Ochiai A, et al. Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: analysis of 240 surgically resected tumors. Cancer. 2000;88:1285–1293.CrossRefPubMed
20.
Zurück zum Zitat Oyama T. Lymph nodal metastasis of M3, SM1 esophageal cancer. Stom Intest. 2002;37:71–74. (in Japanese). Oyama T. Lymph nodal metastasis of M3, SM1 esophageal cancer. Stom Intest. 2002;37:71–74. (in Japanese).
21.
Zurück zum Zitat Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefPubMed
22.
Zurück zum Zitat The Japanese Esophageal Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Tokyo: Kanehara & Co Ltd.; 2012. (in Japanese). The Japanese Esophageal Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus. Tokyo: Kanehara & Co Ltd.; 2012. (in Japanese).
23.
Zurück zum Zitat Murakami Y, Nagata Y, Nishibuchi I, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol. 2012;17:263–271.CrossRefPubMed Murakami Y, Nagata Y, Nishibuchi I, et al. Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer. Int J Clin Oncol. 2012;17:263–271.CrossRefPubMed
24.
Zurück zum Zitat Murakami Y, Takahashi I, Nishibuchi I, et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol. 2015;20:897–904.CrossRefPubMed Murakami Y, Takahashi I, Nishibuchi I, et al. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0). Int J Clin Oncol. 2015;20:897–904.CrossRefPubMed
25.
Zurück zum Zitat Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol. 2009;2:252–256.CrossRefPubMed Miura A, Momma K, Yoshida M. Endoscopic resection for T1a-MM and T1b-SM1 squamous cell carcinoma of the esophagus. Clin J Gastroenterol. 2009;2:252–256.CrossRefPubMed
26.
Zurück zum Zitat Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257:1032–1038.CrossRefPubMed Akutsu Y, Uesato M, Shuto K, et al. The overall prevalence of metastasis in T1 esophageal squamous cell carcinoma: a retrospective analysis of 295 patients. Ann Surg. 2013;257:1032–1038.CrossRefPubMed
27.
Zurück zum Zitat Ito E, Ozawa S, Kijima H, et al. New invasive patterns as a prognostic factor for superficial esophageal cancer. J Gastroenterol. 2012;47:1279–1289.CrossRefPubMed Ito E, Ozawa S, Kijima H, et al. New invasive patterns as a prognostic factor for superficial esophageal cancer. J Gastroenterol. 2012;47:1279–1289.CrossRefPubMed
28.
Zurück zum Zitat Arima M, Yamada T, Tsunomiya I, et al. Strategies for treatment and follow-up observation of patients with superficial esophageal cancer. Shoukakinaisikyou. 2012;24:1237–1244. (in Japanese). Arima M, Yamada T, Tsunomiya I, et al. Strategies for treatment and follow-up observation of patients with superficial esophageal cancer. Shoukakinaisikyou. 2012;24:1237–1244. (in Japanese).
29.
Zurück zum Zitat Fukuhara T, Hiyama T, Tanaka S, et al. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma. Digestion. 2010;82:60–65.CrossRefPubMed Fukuhara T, Hiyama T, Tanaka S, et al. Natural course of lugol-voiding lesions in patients with superficial esophageal squamous cell carcinoma. Digestion. 2010;82:60–65.CrossRefPubMed
30.
Zurück zum Zitat Fukuhara T, Hiyama T, Tanaka S, et al. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol. 2010;44:27–33.CrossRef Fukuhara T, Hiyama T, Tanaka S, et al. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol. 2010;44:27–33.CrossRef
31.
Zurück zum Zitat Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638–643.CrossRefPubMed Kato H, Sato A, Fukuda H, et al. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol. 2009;39:638–643.CrossRefPubMed
32.
Zurück zum Zitat Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–689.CrossRefPubMedPubMedCentral Kurokawa Y, Muto M, Minashi K, Boku N, Fukuda H, Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. A phase II trial of combined treatment of endoscopic mucosal resection and chemoradiotherapy for clinical stage I esophageal carcinoma: Japan Clinical Oncology Group Study JCOG0508. Jpn J Clin Oncol. 2009;39:686–689.CrossRefPubMedPubMedCentral
Metadaten
Titel
Curative Criteria After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinomas
verfasst von
T. Mizumoto
T. Hiyama
S. Oka
N. Yorita
K. Kuroki
M. Kurihara
Y. Yoshifuku
Y. Sanomura
Y. Urabe
Y. Murakami
K. Arihiro
S. Tanaka
K. Chayama
Publikationsdatum
21.03.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 6/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5029-0

Weitere Artikel der Ausgabe 6/2018

Digestive Diseases and Sciences 6/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.